Menu
Dividend AristocratsDividend KingsHigh YieldMonthly DividendDividend CalendarScreener

Danaher Corporation Stock Price History

Danaher Corporation EPS

EPSDividend / share
0.02.34.66.99.22007200920112013201520172019202120232025

Danaher Corporation Dividend per Share

Forward Yield
0.89%
Annual Dividend
1.60 USD
Payout
26.36%
Frequency
Quarterly
Yrs of growth
12
CAGR 5Y
17.73%
Status
Dividend Grower
0.00.30.71.01.419951998200120042007201020132016201920222025

Danaher Corporation Dividend Yield

Danaher Corporation Payout Ratio

0%7%14%21%27%2007200920112013201520172019202120232025

Danaher Corporation Dividend Growth

1Y CAGR
3Y CAGR
5Y CAGR
10Y CAGR
20Y CAGR
18.52%
17.65%
17.73%
18.03%
31.15%
Compound annual growth rate of dividend per share
Yield vs sector
0.89%
avg Healthcare: 2.97%
Next ex-dividend (est.)
2026-06-26
last: 2026-03-27
Ex-DateAmount
2026-03-270.40 USD
2025-12-260.32 USD
2025-09-260.32 USD
2025-06-270.32 USD
2025-03-280.32 USD
2024-12-270.27 USD
2024-09-270.27 USD
2024-06-280.27 USD

Danaher Corporation is a leading science and technology company that designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. It operates primarily through three key segments: Biotechnology, which provides tools and services for bioprocessing, genomics, and proteomics; Life Sciences, offering advanced instrumentation for research in microscopy, flow cytometry, and mass spectrometry; and Diagnostics, delivering clinical instruments, software, and consumables for laboratory diagnostics, pathology, and healthcare settings. Danaher Corporation's portfolio includes diagnostic equipment, digital imaging systems, optical instruments, microscopes, water quality control systems, and disinfection solutions, serving healthcare providers, research institutions, pharmaceutical companies, and industrial clients. These offerings support critical applications in drug discovery, disease diagnosis, environmental monitoring, and quality assurance across global markets. Founded in 1984 and headquartered in Washington, District of Columbia, Danaher Corporation plays a vital role in advancing scientific innovation and improving health outcomes through its integrated solutions.